Cancer immunotherapy works by mobilizing the body's own immune system to recognize and destroy malignant cells.

In certain contexts, the Notch receptor may participate in “reverse signaling,” influencing neighboring cells directly.

The data shows that immune cells converge at sites of motor neuron loss and TDP-43 pathology with distinct patterns depending ...

Using advanced genetic and spatial analysis techniques, researchers discovered evidence that ALS unfolds through a ...

The case for natural killer cell-based immunotherapy has been one of the longer-running theses in clinical oncology. NK cells ...

Triple-negative breast cancer and several other hard-to-treat tumors may have found an unlikely weak spot. It involves the ...

Across the immunity cycle, NPs can co-deliver tumor antigens and adjuvants to DCs, enhance major histocompatibility complex class I (MHC-I)-mediated cross-presentation, and promote cytotoxic T ...

UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...

Glioblastoma is a highly lethal brain tumor, and its outer edges are unexpectedly more viscous than its core. This physical ...

The 2026 Gruber Genetics Prize is being awarded to Alan G Hinnebusch, PhD, a Distinguished Investigator at the National ...

Chronic lung diseases, such as COPD, pulmonary fibrosis and BPD, impose heavy global health burdens with high morbidity and mortality. Recent studies have ...

The immune system exhibits remarkable plasticity, enabling dynamic responses to environmental cues while maintaining tissue homeostasis. Emerging evidence ...